Absci gained on animal testing phaseout news, but the change has limited near-term impact on its investment case. Read why ...

Absci Corporation stock has dropped since January, driven by weak earnings and broader biotech sector pressures. Learn more about ABSI stock here.

The deal is structured as a private investment in a public equity and includes an equity stake in Absci. AMD didn’t disclose the amount of its stake. AMD, which is based in Santa Clara ...

Absci management will webcast a corresponding ... we are going to take a look at where Advanced Micro Devices, Inc. (NASDAQ:AMD) stands against other AI stocks. As per a CNBC report, in 2025 ...

Vancouver, Wash.-based Absci said the investment is structured as a private investment in public equity, or PIPE deal. AMD will support Absci in creating better biologics for patients using its ...

Artificial intelligence is increasingly becoming a cornerstone in pharmaceutical research, with numerous companies leveraging ...

The Philadelphia Semiconductor Index fell 7.97%, with all 30 components closing lower. AMD dropped 8.41%, Broadcom declined 6.94%, Qualcomm fell 6.4%, Arm Holdings slid 5.75%, ASML dipped 5.49%, and ...

SANTA CLARA, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced “Advancing AI 2025,” an in-person and livestreamed event on June 12, 2025. The industry event will ...

7 analysts have expressed a variety of opinions on Absci (NASDAQ:ABSI) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their ...

Absci has a 1-year low of $2.01 and a 1-year high of $6.33. The business’s fifty day moving average price is $3.58 and its two-hundred day moving average price is $3.51.

VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be ...